XP Chemistries (XPC.ST) Stock Analysis & AI Equity Report
XP Chemistries (XPC.ST) overview
XP Chemistries (XPC.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, XP Chemistries reported revenue of SEK 0.3m and operating profit of SEK -10.6m; the year-end share price was 0.18 SEK and market capitalisation was SEK 35.7m. XP Chemistries is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get XP Chemistries's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-05-21. Data will be refreshed during report generation.
About XP Chemistries
XP Chemistries AB develops and produces forest-based capsaicin and capsaicin analogues using patented catalytic technology and renewable feedstocks. The company focuses on fine chemicals and biologically active products for animal feed, cosmetics, personal care, and self-defense spray applications, while also carrying out research, development, and patent management related to these compounds.
Generate the XP Chemistries report
XP Chemistries is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for XP Chemistries and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.